Correlation Between Aquestive Therapeutics and Vitamin Blue
Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and Vitamin Blue at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and Vitamin Blue into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aquestive Therapeutics and Vitamin Blue, you can compare the effects of market volatilities on Aquestive Therapeutics and Vitamin Blue and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of Vitamin Blue. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and Vitamin Blue.
Diversification Opportunities for Aquestive Therapeutics and Vitamin Blue
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Aquestive and Vitamin is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and Vitamin Blue in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vitamin Blue and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with Vitamin Blue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vitamin Blue has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and Vitamin Blue go up and down completely randomly.
Pair Corralation between Aquestive Therapeutics and Vitamin Blue
If you would invest 160.00 in Aquestive Therapeutics on September 12, 2024 and sell it today you would earn a total of 222.00 from holding Aquestive Therapeutics or generate 138.75% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aquestive Therapeutics vs. Vitamin Blue
Performance |
| Timeline |
| Aquestive Therapeutics |
| Vitamin Blue |
Aquestive Therapeutics and Vitamin Blue Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aquestive Therapeutics and Vitamin Blue
The main advantage of trading using opposite Aquestive Therapeutics and Vitamin Blue positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, Vitamin Blue can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vitamin Blue will offset losses from the drop in Vitamin Blue's long position.| Aquestive Therapeutics vs. Evoke Pharma | Aquestive Therapeutics vs. Dynavax Technologies | Aquestive Therapeutics vs. Amphastar P | Aquestive Therapeutics vs. Lantheus Holdings |
| Vitamin Blue vs. Golden Matrix Group | Vitamin Blue vs. Aquestive Therapeutics | Vitamin Blue vs. Playstudios | Vitamin Blue vs. Amgen Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |